GLP-1 diabetes drugs linked to modest increase in hair loss risk, BMJ study shows
The University of Pennsylvania-led study found hazard ratios of 1.37 and 1.68 for alopecia with GLP-1 receptor agonists versus SGLT-2 and DPP-4 inhibitors.
24 JUL
· 3 min read
